Literature DB >> 17942306

Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues.

Asunción Burguete1, Eleni Pontiki, Dimitra Hadjipavlou-Litina, Raquel Villar, Esther Vicente, Beatriz Solano, Saioa Ancizu, Silvia Pérez-Silanes, Ignacio Aldana, Antonio Monge.   

Abstract

We report the synthesis, anti-inflammatory and antioxidant activities of novel ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues. The tested compounds inhibit the carrageenin-induced rat paw edema (4.5-56.1%) and present important scavenging activities. Compound 2a is the most potent (56.1%) in the in vivo experiment and exhibits promising in vitro inhibition of soybean lipoxygenase (IC(50)<1microM).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942306     DOI: 10.1016/j.bmcl.2007.10.002

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Studies of new peroxyoxalate-H2O2 chemiluminescence system using quinoxaline derivatives as green fluorophores.

Authors:  Abdolraouf Samadi-Maybodi; Reza Akhoondi; Mohammad Javad Chaichi
Journal:  J Fluoresc       Date:  2010-03-10       Impact factor: 2.217

2.  One-pot synthesis of biologically active 1,2,3-trisubstituted pyrrolo[2,3-b]quinoxalines through a palladium-catalyzed reaction with internal alkyne moieties.

Authors:  Ali Keivanloo; Tayebeh Besharati-Seidani; Babak Kaboudin; Akihiro Yoshida; Tsutomu Yokomatsu
Journal:  Mol Divers       Date:  2018-06-16       Impact factor: 2.943

3.  Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.

Authors:  Mery Santivañez-Veliz; Silvia Pérez-Silanes; Enrique Torres; Elsa Moreno-Viguri
Journal:  Bioorg Med Chem Lett       Date:  2016-03-18       Impact factor: 2.823

4.  An efficient protocol for the synthesis of quinoxaline derivatives at room temperature using recyclable alumina-supported heteropolyoxometalates.

Authors:  Diego M Ruiz; Juan C Autino; Nancy Quaranta; Patricia G Vázquez; Gustavo P Romanelli
Journal:  ScientificWorldJournal       Date:  2012-03-12

5.  Esters of Quinoxaline 1`4-Di-N-oxide with Cytotoxic Activity on Tumor Cell Lines Based on NCI-60 Panel.

Authors:  Gildardo Rivera; Syed Shoaib Ahmad Shah; Daniel Arrieta-Baez; Isidro Palos; Antonio Mongue; Luvia Enid Sánchez-Torres
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

6.  Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.

Authors:  Mohamed Alswah; Ashraf H Bayoumi; Kamal Elgamal; Ahmed Elmorsy; Saleh Ihmaid; Hany E A Ahmed
Journal:  Molecules       Date:  2017-12-27       Impact factor: 4.411

Review 7.  Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.

Authors:  Guyue Cheng; Wei Sa; Chen Cao; Liangliang Guo; Haihong Hao; Zhenli Liu; Xu Wang; Zonghui Yuan
Journal:  Front Pharmacol       Date:  2016-03-21       Impact factor: 5.810

Review 8.  Current status of pyrazole and its biological activities.

Authors:  Mohd Javed Naim; Ozair Alam; Farah Nawaz; Md Jahangir Alam; Perwaiz Alam
Journal:  J Pharm Bioallied Sci       Date:  2016 Jan-Mar

9.  Unexpected reduction of ethyl 3-phenylquinoxaline-2- carboxylate 1,4-di-N-oxide derivatives by amines.

Authors:  Lidia M Lima; Esther Vicente; Beatriz Solano; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge
Journal:  Molecules       Date:  2008-01-17       Impact factor: 4.411

10.  Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine⁻Pyrazole Hybrid Derivatives.

Authors:  Eman M Flefel; Walaa I El-Sofany; Mahmoud El-Shahat; Arshi Naqvi; Eman Assirey
Journal:  Molecules       Date:  2018-10-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.